Ruscetta, V.M.; Seaton, T.J.; Shakeel, A.; Vasconcelos, S.N.S.; Viirre, R.D.; Adler, M.J.; Olson, M.F.
Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics. Cells 2023, 12, 534.
https://doi.org/10.3390/cells12040534
AMA Style
Ruscetta VM, Seaton TJ, Shakeel A, Vasconcelos SNS, Viirre RD, Adler MJ, Olson MF.
Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics. Cells. 2023; 12(4):534.
https://doi.org/10.3390/cells12040534
Chicago/Turabian Style
Ruscetta, Vanessa M., Taj J. Seaton, Aleen Shakeel, Stanley N. S. Vasconcelos, Russell D. Viirre, Marc J. Adler, and Michael F. Olson.
2023. "Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics" Cells 12, no. 4: 534.
https://doi.org/10.3390/cells12040534
APA Style
Ruscetta, V. M., Seaton, T. J., Shakeel, A., Vasconcelos, S. N. S., Viirre, R. D., Adler, M. J., & Olson, M. F.
(2023). Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics. Cells, 12(4), 534.
https://doi.org/10.3390/cells12040534
